A P Nayak1, B J Green1, A R Lemons1, N B Marshall1, W T Goldsmith1, M L Kashon1, S E Anderson1, D R Germolec2, D H Beezhold1. 1. Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA. 2. Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
Abstract
BACKGROUND: Epidemiological surveys indicate that occupants of mold contaminated environments are at increased risk of respiratory symptoms. The immunological mechanisms associated with these responses require further characterization. OBJECTIVE: The aim of this study was to characterize the immunotoxicological outcomes following repeated inhalation of dry Aspergillus fumigatus spores aerosolized at concentrations potentially encountered in contaminated indoor environments. METHODS: Aspergillus fumigatus spores were delivered to the lungs of naïve BALB/cJ mice housed in a multi-animal nose-only chamber twice a week for a period of 13 weeks. Mice were evaluated at 24 and 48 h post-exposure for histopathological changes in lung architecture, recruitment of specific immune cells to the airways, and serum antibody responses. RESULT: Germinating A. fumigatus spores were observed in lungs along with persistent fungal debris in the perivascular regions of the lungs. Repeated exposures promoted pleocellular infiltration with concomitant epithelial mucus hypersecretion, goblet cell metaplasia, subepithelial fibrosis and enhanced airway hyperreactivity. Cellular infiltration in airways was predominated by CD4(+) T cells expressing the pro-allergic cytokine IL-13. Furthermore, our studies show that antifungal T cell responses (IFN-γ(+) or IL-17A(+) ) co-expressed IL-13, revealing a novel mechanism for the dysregulated immune response to inhaled fungi. Total IgE production was augmented in animals repeatedly exposed to A. fumigatus. CONCLUSIONS & CLINICAL RELEVANCE: Repeated inhalation of fungal aerosols resulted in significant pulmonary pathology mediated by dynamic shifts in specific immune populations and their cytokines. These studies provide novel insights into the immunological mechanisms and targets that govern the health outcomes that result from repeated inhalation of fungal bioaerosols in contaminated environments. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.
BACKGROUND: Epidemiological surveys indicate that occupants of mold contaminated environments are at increased risk of respiratory symptoms. The immunological mechanisms associated with these responses require further characterization. OBJECTIVE: The aim of this study was to characterize the immunotoxicological outcomes following repeated inhalation of dry Aspergillus fumigatus spores aerosolized at concentrations potentially encountered in contaminated indoor environments. METHODS:Aspergillus fumigatus spores were delivered to the lungs of naïve BALB/cJ mice housed in a multi-animal nose-only chamber twice a week for a period of 13 weeks. Mice were evaluated at 24 and 48 h post-exposure for histopathological changes in lung architecture, recruitment of specific immune cells to the airways, and serum antibody responses. RESULT: Germinating A. fumigatus spores were observed in lungs along with persistent fungal debris in the perivascular regions of the lungs. Repeated exposures promoted pleocellular infiltration with concomitant epithelial mucus hypersecretion, goblet cell metaplasia, subepithelial fibrosis and enhanced airway hyperreactivity. Cellular infiltration in airways was predominated by CD4(+) T cells expressing the pro-allergic cytokine IL-13. Furthermore, our studies show that antifungal T cell responses (IFN-γ(+) or IL-17A(+) ) co-expressed IL-13, revealing a novel mechanism for the dysregulated immune response to inhaled fungi. Total IgE production was augmented in animals repeatedly exposed to A. fumigatus. CONCLUSIONS & CLINICAL RELEVANCE: Repeated inhalation of fungal aerosols resulted in significant pulmonary pathology mediated by dynamic shifts in specific immune populations and their cytokines. These studies provide novel insights into the immunological mechanisms and targets that govern the health outcomes that result from repeated inhalation of fungal bioaerosols in contaminated environments. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.
Authors: Sachin N Baxi; Michael L Muilenberg; Christine A Rogers; William J Sheehan; Jonathan Gaffin; Perdita Permaul; Lianne S Kopel; Peggy S Lai; Jeffrey P Lane; Ann Bailey; Carter R Petty; Chunxia Fu; Diane R Gold; Wanda Phipatanakul Journal: Pediatr Allergy Immunol Date: 2013-11 Impact factor: 6.377
Authors: Lauren M Lilly; Melissa A Gessner; Chad W Dunaway; Allison E Metz; Lisa Schwiebert; Casey T Weaver; Gordon D Brown; Chad Steele Journal: J Immunol Date: 2012-08-29 Impact factor: 5.422
Authors: Eric B Brandt; Melinda Butsch Kovacic; Gerald B Lee; Aaron M Gibson; Thomas H Acciani; Timothy D Le Cras; Patrick H Ryan; Alison L Budelsky; Gurjit K Khurana Hershey Journal: J Allergy Clin Immunol Date: 2013-09-20 Impact factor: 10.793
Authors: Cassandra Collins; Thomas M Keane; Daniel J Turner; Grainne O'Keeffe; David A Fitzpatrick; Sean Doyle Journal: J Proteome Res Date: 2013-05-28 Impact factor: 4.466
Authors: Amanda D Buskirk; Brett J Green; Angela R Lemons; Ajay P Nayak; W Travis Goldsmith; Michael L Kashon; Stacey E Anderson; Justin M Hettick; Steven P Templeton; Dori R Germolec; Donald H Beezhold Journal: PLoS One Date: 2014-10-23 Impact factor: 3.240
Authors: Yuefeng Huang; Liying Guo; Jin Qiu; Xi Chen; Jane Hu-Li; Ulrich Siebenlist; Peter R Williamson; Joseph F Urban; William E Paul Journal: Nat Immunol Date: 2014-12-22 Impact factor: 25.606
Authors: Watcharoot Kanchongkittiphon; Mark J Mendell; Jonathan M Gaffin; Grace Wang; Wanda Phipatanakul Journal: Environ Health Perspect Date: 2014-10-10 Impact factor: 9.031
Authors: T L Croston; A P Nayak; A R Lemons; W T Goldsmith; J K Gu; D R Germolec; D H Beezhold; B J Green Journal: Clin Exp Allergy Date: 2016-09-16 Impact factor: 5.018
Authors: Sarah R Haines; Rachel I Adams; Brandon E Boor; Thomas A Bruton; John Downey; Andrea R Ferro; Elliott Gall; Brett J Green; Bridget Hegarty; Elliott Horner; David E Jacobs; Paul Lemieux; Pawel K Misztal; Glenn Morrison; Matthew Perzanowski; Tiina Reponen; Rachael E Rush; Troy Virgo; Celine Alkhayri; Ashleigh Bope; Samuel Cochran; Jennie Cox; Allie Donohue; Andrew A May; Nicholas Nastasi; Marcia Nishioka; Nicole Renninger; Yilin Tian; Christina Uebel-Niemeier; David Wilkinson; Tianren Wu; Jordan Zambrana; Karen C Dannemiller Journal: Build Environ Date: 2019-12-18 Impact factor: 6.456
Authors: Thatcher B Ladd; James A Johnson; Christen L Mumaw; Hendrik J Greve; Xiaoling Xuei; Ed Simpson; Mark A Barnes; Brett J Green; Tara L Croston; Chandrama Ahmed; Angela Lemons; Donald H Beezhold; Michelle L Block Journal: ASN Neuro Date: 2021 Jan-Dec Impact factor: 4.146